Quantification of 31 volatile organic compounds in whole blood using solid-phase microextraction and gas chromatography-mass spectrometry

Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
Journal of Chromatography B (Impact Factor: 2.69). 04/2006; 832(2):292-301. DOI: 10.1016/j.jchromb.2006.01.019
Source: PubMed

ABSTRACT The prevalence of exposure to volatile organic compounds (VOCs) has raised concern about possible health effects resulting from chronic human exposure. To support studies exploring the relation between VOC exposure and health effects, we developed an automated analytical method using solid-phase microextraction (SPME), capillary gas chromatography (GC), and quadrupole mass spectrometry (MS). This method quantifies trace levels (low parts per trillion) of 14 halogenated alkanes, 5 halogenated alkenes, 10 aromatic compounds, and 2 other VOCs in human blood. Detection limits for the SPME-GC-MS method range from 0.005 to 0.12 microg/L, with linear calibration curves spanning three orders of magnitude. The improved throughput of this method will enable us to expand biomonitoring efforts to assess nonoccupational VOC exposure in large epidemiological studies.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Parkinson’s disease (PD) is characterized by dopaminergic (DA) neuron depletion. Early detection of PD may help in selecting the appropriate treatment. Biomarkers of PD have been suggested, however none of these is currently in clinical use. The aim of this study was to identify volatile organic compounds (VOCs) as early biomarkers of PD. Our hypothesis was that during PD progression, specific VOCs are generated that are linked to the biochemical pathways characterizing PD. These VOCs can be detected by GC–MS combined with solid-phase microextraction (SPME) technique. Three groups of rats were studied: DA-lesioned rats injected with 6-hydroxydopamine (HDA; 250 μg/rat n=11); control rats injected with saline (n=9), and control rats injected with DSP-4 (n=8), a specific noradrenergic neuron toxin. Blood and striatal tissue homogenate were analyzed. In the blood, 1-octen-3-ol and 2-ethylhexanol were found at significantly higher concentrations in HDA versus sham rats. In the striatal homogenate 1-octen-3-ol and other four compounds were found at significantly lower concentrations in HDA versus sham rats. 1-Octen-3-ol is a cytotoxic compound. These results may lead to the development of an early diagnostic test for PD based on profiling of VOCs in body fluids.
    Neurochemistry International 10/2014; DOI:10.1016/j.neuint.2014.06.016 · 2.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Needle trap devices (NTDs) have become a promising alternative to solid-phase microextraction (SPME)due to their robustness and exhaustive sampling while maintaining all the advantages of SPME. This studyinvestigates the compromise required in packing NTDs starting from the hypothesis that their diametermakes perfect packing impractical. The most limiting parameter of NTDs is the small amount of sorbentthat can be fitted in the trap. On evaluating packing density, it is found that the densest packing cannotpractically be achieved with NTDs. This poor packing leads to oscillations in the fluid flow profiles andso sampling flows up to 10–15 mL min−1are recommended for this methodology. The limited amount ofsorbent materials inside the needles makes breakthrough another limiting aspect of NTDs. However, oneof the most significant advantages of these devices is that they have a large preconcentration factor, whichresults in method detection limits in the pptv range with sample volumes <100 mL. This methodologygives promising results in the analysis of water saturated samples as the limited amount of sorbentsreduces water retention. Moreover, it is desirable for a small amount of water to be retained with NTDs as this improves the desorption of the retained compounds in the GC injector and allows sharper injectionband-widths to be obtained.
    Journal of Chromatography A 12/2014; 1369:18. DOI:10.1016/j.chroma.2014.09.081 · 4.26 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Exposure to trihalomethanes (or THMs: chloroform, bromoform, bromodichloromethane, and dibromochloromethane [DBCM]) formed via drinking water disinfection has been associated with adverse reproductive outcomes and cancers of the digestive or genitourinary organs. However, few studies have examined potential associations between THMs and liver injury in humans, even though experimental studies suggest that these agents exert hepatotoxic effects, particularly among obese individuals. This study examined participants in the National Health and Nutrition Examination Survey (1999-2006, N=2781) to test the hypothesis that THMs are associated with liver injury as assessed by alanine aminotransferase (ALT) activity in circulation. Effect modification by body mass index (BMI) or alcohol consumption also was examined. Associations between blood THM concentrations and ALT activity were assessed using unconditional multiple logistic regression to calculate prevalence odds ratios (ORs) with 95% confidence intervals (CIs) for exposure among cases with elevated ALT activity (men: >40IU/L, women: >30IU/L) relative to those with normal ALT, after adjustment for variables that may confound the relationship between ALT and THMs. Compared to controls, cases were 1.35 times more likely (95% CI: 1.02, 1.79) to have circulating DBCM concentrations exceeding median values in the study population. There was little evidence for effect modification by BMI, although the association varied by alcohol consumption. Among non-drinkers, cases were more likely than controls to be exposed to DBCM (OR: 3.30, 95% CI: 1.37, 7.90), bromoform (OR: 2.88, 95% CI: 1.21, 6.81), or brominated THMs (OR: 4.00, 95% CI: 1.31, 12.1), but no association was observed among participants with low, or moderate to heavy alcohol consumption. Total THM levels exceeding benchmark exposure limits continue to be reported both in the United States and globally. Results from this study suggest a need for further characterization of ALT activity and possibly other hepatic or metabolic diseases in populations with elevated drinking water THM concentrations. Copyright © 2015. Published by Elsevier B.V.
    Science of The Total Environment 07/2015; 521. DOI:10.1016/j.scitotenv.2015.03.050 · 3.16 Impact Factor

Full-text (2 Sources)

Available from
Oct 3, 2014